Abstract
In this study, non-rigid analogs of thalidomide have been designed in order to develop potentially active, more effective and safer lead molecules for disorders caused or contributed by inflammation. Five different series of acylaminoacetamide compounds were synthesized, and the biological inhibitory potency of the title compounds has been determined by evaluating their effects on COX-2 isoenzyme expression and PGE2 production in A549 (human lung adenocarcinoma) cell lines. Among the studied series, N-[2-(isopropylamino)-2-oxoethyl]isonicotinamide is the most active inhibitory compound on COX-2 isoenzyme expression, and N-[2-oxo-2-(pyrolydine-1-yl)etyl]isonicotinamide is the most active inhibitory compound on the biosynthesis of PGE2. Molecular docking studies and molecular dynamics simulations were also applied to investigate non-covalent interactions of the most active compounds inside the active side of the crystal structure of murine cyclooxygenase 2 (mCOX-2) isoenzyme.
Similar content being viewed by others
Abbreviations
- ATCC:
-
American Type Culture Collection
- BCA:
-
Bicinchoninic acid
- COX-1:
-
Cyclooxygenase-1
- COX-2:
-
Cyclooxygenase-2
- COX-3:
-
Cyclooxygenase-3
- DMEM:
-
Dulbecco’s modified Eagle’s medium
- DMSO:
-
Dimethyl sulfoxide
- EDTA:
-
Ethylenediaminetetraacetic acid
- EIA:
-
Enzyme immunoassay
- ESI:
-
Electrospray ionization
- FDA:
-
United States Food and Drug Administration
- GB:
-
Generalized Born
- IL-1β:
-
Interleukin-1β
- mCOX-2:
-
Murine cyclooxygenase 2
- MD:
-
Molecular dynamics
- MM-GBSA:
-
Molecular mechanics–Generalized Born surface area
- MM-PBSA:
-
Molecular mechanics–Poisson–Boltzmann surface area
- NMR:
-
Nuclear magnetic resonance
- PBS:
-
Phosphate-buffered saline
- PGE2 :
-
Prostaglandin E2
- PME:
-
Particle mesh Ewald
- RIPA:
-
Radioimmunoprecipitation assay
- RMSD:
-
Root-mean-square deviation
- SDS-PAGE:
-
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
References
Aggarwal B, Shishodia S, Sandur S, Pandey M, Sethi G (2006) Inflammation and cancer: how hot is the link? Biochem Pharmacol 72:1605–1621
Al-Maghrabi J, Buhmedia A, Emam E, Syrjänen K, Sibiany A, Al-Qahtani M, Al-Ahwal M (2012) Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma. World J Gastroenterol 18:1793–1799
Blanco MM, Schapira CB, Levin G, Perillo (2005) IA 1,6- and 1,7-naphthyridines—IV: synthesis of hydroxycarboxamide derivates. Bull J Heterocycl Chem 42:493–502
Brandl M, Weiss MS, Jabs A, Sühnel J, Hingenfeld R (2001) C–H π-interactions in proteins. J Mol Biol 307:357–377
Case DA, Darden TA, Cheatham TE, Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM, Roberts B, Hayik S, Roitberg A, Seabra G, Swails J, Goetz AW, Kolossvàry I, Wong KF, Paesani F, Vanicek J, Wolf RM, Liu J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Wang J, Hsieh MJ, Cui G, Roe DR, Mathews DH, Seetin MG, Salomon-Ferrer R, Sagui C, Babin V, Luchko T, Gusarov S, Kovalenko A, Kollman PA (2012) Amber 12, University of California, San Francisco
Chen IJ, Foloppe N (2008) Conformational sampling of druglike molecules with MOE and catalyst: implications for pharmacophore modelling and virtual screening. J Chem Inf Model 48:1773–1791
Chou KC (2004) Structural bioinformatics and its impact to biomedical science. Curr Med Chem 16:2105–2134
Cornell WD, Cleplak P, Bayly CI, Gould IR, Merz KM Jr, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, Kollman PA (1995) A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J Am Chem Soc 117:5179–5197
Costa C, Incio J, Soares R (2007) Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 10:149–166
DeCicco KL, Tanaka T, Andreola F, De Luca LM (2004) The effect of thalidomide on non-small cell lung cancer (NSCLC) cell lines: possible involvement in the PPAR gamma pathway. Carcinogenesis 25:1805–1812
Eldridge MD, Murray CW, Auton TR, Paolini GV, Mee RP (1997) Empirical scoring functions—I: the development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J Comput Aided Mol Des 11:425–445
Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG (1995) A smooth particle mesh Ewald method. J Chem Phys 103:8577–8593
Fabiola F, Bertram R, Korostelev A, Chapman MS (2002) An improved hydrogen bond potential: impact on medium resolution protein structures. Protein Sci 11:1415–1423
Farese A, Peytou V, Condom R, Sinet M, Patino N, Kirn A, Moog C, Aubertin AM, Guedj R (1996) Synthesis of analogues of the benzodiazepine Ro-5-3335, antagonist of Tat HIV-1: biological evaluation by luciferase transactivation and anti-viral assay. J Med Chem 31:497–505
Grace Development Team, Weizmann Institute of Science, Israel. http://plasma-gate.weizmann.ac.il/Grace/
Gasparini G, Longo R, Sarmiento R, Morabito A (2003) Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? Lancet Oncol 4:605–615
Gros L, Lorente Jimenez SO, Yardley V, Rattray L, Wharton H, Little S, Croft SL, Ruiz-Perez LM, Gonzalez-Pacanowska D, Gilbert IH (2006) Evaluation of azasterols as anti-parasitics. J Med Chem 49:6094–6103
Hermes Visualiser. http://www.ccdc.cam.ac.uk/Solutions/GoldSuite/Pages/Hermes.aspx
Halgren TA (1996) Merck molecular force field—I: basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem 17:490–519
Harousseau JL (2010) Ten years of improvement in the management of multiple myeloma: 2000–2010. Clin Lymphoma Myeloma Leuk 10:424–442
Hashimoto Y (2002) Structural development of biological response modifiers based on thalidomide. Bioorg Med Chem 10:461–479
Hashimoto Y (2008) Thalidomide as a multi-template for development of biologically active compounds. Arch Pharm 341:536–547
Haworth RD, Peacock DH, Smith WR, MacGillivary R (1952) The action of formaldehyde on proteins—part II: some reactions of N-hydroxymethylamides. J Chem Soc 2972–2980
Heravi RE, Hadizadeh F, Sankian M, Afshari JT, Taghdisi SM, Jafarian H, Behravan J (2011) Novel selective COX-2 inhibitors induce apoptosis in caco-2 colorectal carcinoma cell line. Eur J Pharm Sci 44:479–486
Hesse M, Meier H, Zeeh B (1997) Spectroscopic methods in organic chemistry, 1st edn. Thieme, New York
Huang M, Stolina M, Sharma S, Mao JT, Zhu L, Miller PW, Wollman J, Herschman H, Dubinett SM (1998) Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res 58:1208–1216
Hyde CAC, Missailidis S (2009) Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. Int Immunopharmacol 9:701–715
Jakalian A, Bush BL, Jack DB, Bayly CI (2000) Fast, efficient generation of high-quality atomic charges: AM1-BCC model—I: method. J Comput Chem 21:132–146
Jiang Q, Wong J, Fyrst H, Saba JD, Ames BN (2004) γ-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc Natl Acad Sci USA 101:17825–17830
Jones G, Willett P, Glen RC (1995) Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J Mol Biol 245:43–53
Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727–748
Jorgensen WL, Chandrasekhar J, Madura JD (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926–935
Koeberle A, Siemoneit U, Bühring U, Northoff H, Laufer S, Albrecht W, Werz O (2008) Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1. J Pharmacol Exp Ther 326:975–982
Ku GY, Ilson DH (2010) Esophagogastric cancer: targeted agents. Cancer Treat Rev 36:235–248
Kurita K, Nishibori T, Harata M (2002) Synthesis and asymmetric reducing performance of chitin/dihydronicotinamide conjugates having glycine or l-leucine spacer arms. Biomacromolecules 3:705–709
Ling H, Jia X, Zang Y, Gapter LA, Lim Y, Agarwal R, Ng K (2010) Pachymic acid inhibits cell growth and modulates arachidonic acid metabolism in nonsmall cell lung cancer A549 cells. Mol Carcinog 49:271–282
Luo W, Yu Q, Salcedo I, Holloway HW, Lahiri DK, Brossi A, Tweedie D, Greig NH (2011) Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-α inhibitory activity. Bioorg Med Chem 19:3965–3972
Macciò A, Madeddu C (2012) Inflammation and ovarian cancer. Cytokine 58:133–147
Mao JT, Cui XY, Reckamp K, Liu M, Krysan K, Dalwadi H, Sharma S, Hazra S, Strieter R, Gardner B, Dubinett SM (2005) Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer. Clin Lung Cancer 7:30–39
Massova I, Kollman PA (2000) Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspect Drug Discov 18:113–135
Miller BR III, Roitberg AE (2013) Design of e-pharmacophore models using compounds fragments for the trans-sialidese of Trypanosoma cruzi: screening for novel inhibitor scaffolds. J Mol Graph Model 45:84–97
Miller BR III, McGee TD Jr, Swails JM, Homeyer N, Gohlke H, Roitberg AE (2012) MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput 8:3314–3321
Mitchell JA, Belvisi MG, Akarasereenont P, Robbins RA, Kwon OJ, Croxtall J, Barnes PJ, Vane JR (1994) Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol 113:1008–1014
Molecular Operating Environment (MOE 2013.08) Chemical Computing Group Inc., 1010 Sherbrooke Street West, Suite 910, Montreal H3A 2R7, Canada
Naumova BS, Chekmareva IB, Zhdanovich ES, Preobrazanskii NA (1969) Production of nicotinic acid derivatives. Khim Farm Zh 5:11–12
Noguchi T, Shimazawa R, Nagasawa K, Hashimoto Y (2002) Thalidomide and its analogues as cyclooxygenase inhibitors. Bioorg Med Chem Lett 12:1043–1046
Onn A, Tseng JE, Herbst RS (2001) Thalidomide, cyclooxygenase-2, and angiogenesis: potential for therapy. Clin Cancer Res 7:3311–3313
Phillis JW, Horrocks LA, Farooqui AA (2006) Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res Rev 52:201–243
Prins MJD, Verhage RJJ, ten Kate FJW, Van Hillegersberg R (2012) Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma. J Gastrointest Surg 16:956–966
Roe DR, Cheatham TE III (2013) PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput 9:3084–3095
Ryckaert JP, Ciccotti G, Berendsen HJC (1977) Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 23:327–341
Salvado MD, Alfranca A, Haeggström JZ, Redondo JM (2012) Prostanoids in tumor angiogenesis: therapeutic intervention beyond COX-2. Trends Mol Med 18:233–243
Sampaio EP, Carvalho DS, Nery JAC, Lopes UG, Sarno EN (2006) Thalidomide: an overview of its pharmacological mechanisms of action. Anti Inflamm Anti Allergy Agents Med Chem 5:71–77
Sano H, Noguchi T, Tanatani A, Hashimoto Y, Miyachi H (2005) Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide. Bioorg Med Chem 13:3079–3091
Schneider CA, Rasband WS and Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 671
Schwyzer R, Feurer M, Iselin B (1955) Über aktivierte ester—III: umsetzungen aktivierter ester von aminosaure und peptid-derivaten mit aminen und aminosaureestern. Helv Chim Acta 19:83–91
Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V (2012) Multifaceted link between cancer and inflammation. Biosci Rep 32:1–15
Sievers E, Bart R, Backhus L, Lin Y, Starnes M, Castanos R, Starnes V, Bremner R (2005) Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung cancer for dose-dependent effect. J Thorac Cardiovasc Sur 129:1242–1249
Singh KK, Singh MK, Singh RM (1994) Transformation of N-acylaminoacetanilides and N-benzoylglycine hydrazides into 4-(N, N-dimethylaminomethylene)-2-aryl-2-oxazolin-5-ones using Vilsmeier-Haack reagent and their reactions with nucleophiles. Indian J Chem Sect B Org Chem Incl Med Chem 33:1119–1122
Smith CJ, Mckay GA, Fisher M (2008) Colorectal cancer and cyclooxygenase 2 inhibition. Int J Clin Pract 62:810–815
Smith B, Chang HH, Medda F, Gokhale V, Dietrich J, Davis A, Meuillet EJ, Hulme C (2012) Synthesis and biological activity of 2-aminothiazoles as novel inhibitors of PGE2 production in cells. Bioorg Med Chem Lett 22:3567–3570
Takahashi H, Tsuboyama S, Umezawa Y, Honda K, Nishio M (2000) CH/π interactions as demonstrated in the crystal structure of host/guest compounds. a database study. Tetrahedron 56:6185–6191
Thomsen I, Pedersen U, Rasmussen PB, Yde B, Andersen TP, Lawesson SO (1983) Novel and convenient methods for the preparation of substituted thiophenes, thiazoles, and 1,3,4-thiadiazole-2(3H)-thiones from bifunctional substrates. Chem Lett 6:809–810
Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25:1157–1174
Acknowledgments
This study was supported by research grants from Ege University (Project Number: 2009/Ecz/015). We also thank Pharmaceutical Sciences Research Centre (FABAL) of Ege University Faculty of Pharmacy for equipmental support.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Coban, G., Kose, F.A., Kirmizibayrak, P.B. et al. Synthesis, biological activity screening and molecular modeling study of acylaminoacetamide derivatives. Med Chem Res 24, 3710–3729 (2015). https://doi.org/10.1007/s00044-015-1419-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-015-1419-4